Published in Hum Vaccin Immunother on July 22, 2016
Protection by BCG vaccine against tuberculosis: a systematic review of randomized controlled trials. Clin Infect Dis (2013) 4.26
Modeling the impact of global tuberculosis control strategies. Proc Natl Acad Sci U S A (1998) 3.22
Epidemiological benefits of more-effective tuberculosis vaccines, drugs, and diagnostics. Proc Natl Acad Sci U S A (2009) 2.78
Prospects for tuberculosis elimination. Annu Rev Public Health (2012) 2.50
Eliminating human tuberculosis in the twenty-first century. J R Soc Interface (2008) 2.00
Interferon-Gamma Release Assays versus Tuberculin Skin Testing for the Diagnosis of Latent Tuberculosis Infection: An Overview of the Evidence. Pulm Med (2013) 1.98
Systematic review of the use and value of computer simulation modelling in population health and health care delivery. J Public Health Med (2003) 1.91
The development and impact of tuberculosis vaccines. Cell (2006) 1.50
Systematic review and meta-analysis of the current evidence on the duration of protection by bacillus Calmette-Guérin vaccination against tuberculosis. Health Technol Assess (2013) 1.31
Mathematical models for the economic allocation of tuberculosis control activities in developing nations. Am Rev Respir Dis (1967) 1.23
Impact and cost-effectiveness of new tuberculosis vaccines in low- and middle-income countries. Proc Natl Acad Sci U S A (2014) 1.21
The reinfection threshold promotes variability in tuberculosis epidemiology and vaccine efficacy. Proc Biol Sci (2004) 1.20
Tuberculosis 2000-2010: control, but not elimination. Int J Tuberc Lung Dis (2000) 1.16
Making wider use of the world's most widely used vaccine: Bacille Calmette-Guerin revaccination reconsidered. J R Soc Interface (2013) 1.06
Tuberculosis vaccines and prevention of infection. Microbiol Mol Biol Rev (2014) 1.03
Modeling the effects of strain diversity and mechanisms of strain competition on the potential performance of new tuberculosis vaccines. Proc Natl Acad Sci U S A (2008) 1.00
Potential public health impact of new tuberculosis vaccines. Emerg Infect Dis (2004) 0.94
Global stability of an age-structure model for TB and its applications to optimal vaccination strategies. Math Biosci (1998) 0.93
Heterogeneity in susceptibility to infection can explain high reinfection rates. J Theor Biol (2009) 0.92
Questionnaire to assess relevance and credibility of modeling studies for informing health care decision making: an ISPOR-AMCP-NPC Good Practice Task Force report. Value Health (2014) 0.92
Potential cost-effectiveness of a new infant tuberculosis vaccine in South Africa--implications for clinical trials: a decision analysis. PLoS One (2014) 0.92
Cost-effectiveness of novel vaccines for tuberculosis control: a decision analysis study. BMC Public Health (2011) 0.89
Economic evaluation of universal BCG vaccination of Japanese infants. Int J Epidemiol (2001) 0.86
Potential impact of tuberculosis vaccines as epidemic control agents. Clin Infect Dis (2000) 0.86
Modelling the effects of pre-exposure and post-exposure vaccines in tuberculosis control. J Theor Biol (2008) 0.82
A model of tuberculosis transmission and intervention strategies in an urban residential area. Comput Biol Chem (2010) 0.81
Implications of partial immunity on the prospects for tuberculosis control by post-exposure interventions. J Theor Biol (2007) 0.81
Modelling the cost-effectiveness of a new infant vaccine to prevent tuberculosis disease in children in South Africa. Cost Eff Resour Alloc (2014) 0.78
Potential impact of spatially targeted adult tuberculosis vaccine in Gujarat, India. J R Soc Interface (2016) 0.77